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Abstract
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Preterm premature rupture of fetal membranes (PPROM) is associated with infection and is one of
the most common causes of preterm birth. Abnormalities of biglycan and decorin, two
extracellular matrix proteoglycans, lead to preterm birth and abnormal fetal membrane
morphology and abnormal signaling in the mouse model as well as being associated with
inflammatory cascades. In humans, decorin dysregulation is associated with inflammation in
PPROM. We investigated biglycan and decorin’s role in inflammation in fetal membranes using
mouse models of intraperitoneal E. coli injections superimposed on biglycan and decorin
deficiency. We assessed outcomes in vivo as well as in vitro using quantitative qPCR, Western
blotting and ELISA techniques. Our results suggest that biglycan and decorin compensate for each
other in the fetal membranes but lose the ability to do so in the setting of inflammation, leading to
decreased latency to preterm birth. Furthermore, our findings suggest that biglycan and decorin
play discrete roles in fetal membrane signaling pathways in inflammation, leading to changes in
expression of MMP-8 and collagen α1VI, two components of the fetal membrane extracellular
matrix that play a role in the pathophysiology of PPROM. In summary, these findings underline
the importance of biglycan and decorin in fetal membranes as targets for the manipulation of fetal
membrane extracellular matrix stability in the setting of inflammation.
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1. Introduction
Preterm birth is the leading cause of newborn morbidity and mortality in the United States
(Murphy et al., 2012). About a third of preterm births are caused by preterm premature
rupture of fetal membranes (PPROM) (Steer 2005). While no therapies for PPROM
currently exist (Ananth and Vintzileos 2006) (Miyazaki et al. 2012) and the pathophysiology
*
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is unclear, infection as well as genetic susceptibility are thought to play a role (Parry and
Strauss 1998; Shen et al. 2008).
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We have shown that mice deficient in biglycan and decorin, two highly homologous
extracellular matrix proteoglycans, deliver their pups prematurely and display fetal
membrane abnormalities in morphology and signaling (Calmus et al. 2011; Wu et al. 2014).
Biglycan and decorin are members of the small leucine-rich proteoglycan (SLRP) family
(Iozzo 1999; Iozzo 2011; Iozzo and Murdoch 1996) and are the most abundant
proteoglycans expressed in human fetal membranes (Gogiel et al. 2003; Meinert et al. 2001;
Valiyaveettil et al. 2004). Biglycan and decorin are involved in a number of biological
processes including tumor angiogenesis and fibrosis (Neill et al. 2013; Neill et al. 2012a;
Neill et al. 2012b), cancer growth (Iozzo and Cohen 1993; Reed et al. 2005; Sofeu Feugaing
et al. 2013), stem cell biology (Berendsen et al. 2011; Bi et al. 2005; Ichii et al. 2012),
myogenesis (Brandan and Gutierrez 2013) and osteoarthritis and osteoporosis (Ameye et al.
2002; Ameye and Young 2002; Nikitovic et al. 2012). Furthermore, biglycan and decorin
are involved in collagen fibrillogenesis and contribute to the mechanical properties of
connective tissues (Chen et al. 2011; Reed and Iozzo 2002; Zhang et al. 2009). The absence
of these proteoglycans leads to a decrease in connective tissue tensile strength (Corsi et al.
2002). Humans with abnormal post-translational processing of biglycan and decorin display
a subtype of Ehlers-Danlos syndrome, a syndrome associated with a decrease in tensile
strength of connective tissues as well as an increased risk of PPROM (Barabas 1966;
Quentin et al. 1990). Furthermore, we have shown that decorin is dysregulated in human
fetal membranes with PPROM (Horgan et al. 2014).
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Beyond their structural roles, both biglycan and decorin have been implicated in a number of
signaling pathways, including the TGF-β pathway. TGF-β signals via Smads (Liu et al.
1996), transcription factors that play a role in the modulation of the extracellular matrix.
Both biglycan and decorin are regulated by TGF-β (Bassols and Massague 1988) and
decorin modulates TGF-β activity via negative feedback mechanisms (Yamaguchi et al.
1990). Smad-2 and -3 regulate downstream gene expression of tissue inhibitors of matrix
metalloproteinases (TIMPs) and collagens (Verrecchia et al. 2001), proteins that in turn
modulate the mechanical stability of the fetal membrane extracellular matrix. Matrix
metalloproteinases (MMPs) are linked to the pathogenesis of PPROM through the
degradation of fetal membrane extracellular matrix proteoglycans and collagens (Ferrand et
al. 2002). Furthermore, mutations in matrix metalloproteinase genes (Fujimoto et al. 2002)
as well as collagen genes (Anum et al. 2009) have been identified as possible predisposing
factors to PPROM. Additionally, proteoglycans interact with MMPs. For example, decorin
induces the expression of MMP-1 (Huttenlocher et al. 1996). Importantly, we have shown
that biglycan and decorin modulate the TGF-β-SMAD-MMP-TIMP-collagen pathway in
fetal membranes in a gestational age dependent manner (Wu et al. 2014).
Substantial clinical data suggest that infection is a significant risk factor for PPROM
(Torricelli et al. 2013). When exposed to an infectious insult, term human fetal membranes
display increased MMP expression (Estrada-Gutierrez et al. 2010). We have shown a link
between infection and decorin expression in human fetal membranes with PPROM (Horgan
et al. 2014). Coupled with studies indicating that biglycan and decorin both play a role in
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inflammatory cascades (Babelova et al. 2009; Merline et al. 2011), these observations
suggest that infection may significantly impact the biglycan and decorin-dependent
signaling pathways that modulate fetal membrane mechanical properties.
However, while we know that mutations leading to abnormal processing of biglycan and
decorin (Barabas 1966; Quentin et al. 1990) as well as infection (Torricelli et al. 2013) play
a role in the pathogenesis of PPROM, the mechanism by which infection modulates the
function of biglycan and decorin and their dependent signaling pathways in the fetal
membranes is not known.

2. Results
2.1. In the setting of inflammation, latency to preterm birth as well as live birth is
decreased in the absence of biglycan and decorin
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In order to assess the role that biglycan and decorin play in the maintenance of gestation to
term in the setting of inflammation, we first examined the natural history of mouse gestation
after the injection of E. coli intraperitoneally into pregnant mice at embryonic day 15. We
found that the period between injection of live E. coli and preterm birth is significantly
decreased in the Bgn+/−;Dcn−/− and Bgn−/−;Dcn+/− nulls compared to the wild-type E. coli
injected mice as well as compared to the PBS injected Bgn+/−;Dcn−/− and Bgn−/−;Dcn+/−
null mice (Figure 1A) (P=0.001). Furthermore, while the incidence of live pup birth is
significantly decreased in the E. coli injected wild-type dams compared to the PBS injected
wild-type dams, it decreased to 0 in the E. coli injected Bgn+/−;Dcn−/− and Bgn−/−;Dcn+/−
mice (Figure 1B) (P=0.004). For comparison with the wild-type, we chose mice that have
only one of four possible SLRP genes (two biglycan and two decorin). These mice are more
affected than the biglycan or decorin single nulls but are less severely affected than the
double nulls (Bgn−/−;Dcn−/−). The Bgn−/−;Dcn−/− mice delivered their pups extremely
prematurely even without the additional environmental insult of an E. coli injection, and are
thus not suitable for this experimental design. While there was no statistically significant
difference in the latency between the E. coli exposed and the saline exposed wild-type mice,
the standard deviation was larger in the E. coli exposed mice, demonstrating a range of
latencies compared to the saline exposed mice from decreased latency to increased latency
with dystocia.
2.2. Biglycan and decorin compensate for each other in fetal membrane transcription in
the absence of inflammation

Author Manuscript

Next, we investigated whether biglycan and decorin would exhibit compensatory
upregulation of gene expression in fetal membranes depending on exposure to the
environmental insult of inflammation. We observed upregulation of biglycan transcript in
decorin null fetal membranes in the absence of inflammation (PBS injected mice) (P=0.05),
and similarly, upregulation of decorin transcript in biglycan null fetal membranes in the
absence of inflammation (P=0.025)(Figure 2A and 2B).
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2.3. Biglycan and decorin compensatory transcription increase does not occur in
inflammation, while decorin transcription is decreased in the E. coli injected mice
compared to the PBS injected mice
Interestingly, the compensatory mechanisms between biglycan and decorin in the fetal
membranes that are present in the absence of inflammation are modified by the presence of
inflammation. In the E. coli injected fetal membranes, biglycan transcription remained
unchanged in the decorin null samples compared to the wild-type samples, thus departing
from the compensatory increase that it displayed in the absence of inflammation. Decorin
transcription also displayed a lack of compensatory upregulation in the biglycan null in the
setting of inflammation. Additionally, in the absence of biglycan, decorin transcription
decreased in the E. coli injected mice compared to the PBS injected mice (P=0.01) (Figure
2A and 2B).
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2.4. MMP-8 decreases in the wild-type and biglycan null fetal membranes in the setting of
inflammation, while it remains unchanged in the decorin null
Next, we assessed the expression of the matrix metalloproteinases that play a significant role
in fetal membrane rupture and PPROM. We found that inflammation leads to a decrease in
MMP-8 expression in both the wild-type (P=0.03) and the biglycan null (P=0.05), but not in
the decorin null, in which it remained unchanged irrespective of the presence of
inflammation (Figure 3). MMP-9 expression was unchanged (data not shown).
2.5. Collagen α1VI gene expression is unchanged in the setting of inflammation in the
absence of biglycan or decorin, while collagen α1VI protein levels are increased
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Given the role that collagens play in the maintenance of connective tissue mechanical
strength and integrity, we next examined the biglycan- and decorin-dependent expression of
collagen α1VI, a biglycan and decorin binding collagen, in inflammation. In the absence or
presence of both biglycan and decorin, there was no change in collagen α1VI gene
transcription levels (Figure 4A). However, in the absence of either biglycan (P=0.05) or
decorin (P=0.03), collagen α1VI protein expression increased in the setting of inflammation
compared to non-inflammation controls (Figure 4B and C).
In summary, these results demonstrate that inflammation exacerbates the gestational
phenotype of the biglycan/decorin null mouse and leads to abnormalities of transcriptional
compensation between biglycan and decorin as well as leading to translational and
transcriptional changes in downstream targets that play a role in fetal membrane stability.

3. Discussion
Author Manuscript

Biglycan and decorin are necessary for the maintenance of gestation to full term in a genedose dependent and compensatory manner (Calmus et al. 2011), while biglycan/decorin null
fetal membranes display abnormal morphology (Wu et al. 2014). In this study, we show that
biglycan and decorin play a role in the maintenance of gestation in the setting of
inflammation as well as in the fetal membrane response to inflammation.
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Others have shown that inflammation leads to preterm birth in the mouse model (Hirsch and
Wang 2005; Reznikov et al. 1999) and is associated with PPROM in humans (Bendon et al.
1999). Our study has demonstrated that the superimposition of an environmental insult, in
this case inflammation, on a genetic defect, leads to an exacerbation of the preterm birth
phenotype compared to the preterm birth phenotype in the setting of an environmental insult
without a genetic mutation. Furthermore, our study of the role of fetal membrane biglycan
and decorin in the context of inflammation has demonstrated important mechanistic insight
into the role of these proteoglycans in the pathophysiology of PPROM.
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Our data indicate that biglycan and decorin compensate for each other in the fetal
membranes by increasing transcription in a compensatory manner in the absence of
inflammation. This compensatory upregulation of biglycan and decorin is similar to
observations in multiple tissues including cornea, kidney, skin, bone and muscle (Ameye
and Young 2002; Corsi et al. 2002; Zhang et al. 2009) and to our observations in the
placenta as well as functionally in vivo during gestation (Calmus et al. 2011). We have not
observed similar upregulation of biglycan protein expression in decorin-null fetal
membranes and vice versa (Calmus et al. 2011). This may be secondary to protein
compensation not being present in the fetal membranes or it may be because compensatory
changes are present but not readily apparent with the techniques we utilized given the
abundance of both SLRPs in fetal membranes. Interestingly, this ability to compensate for
each other is disrupted by the presence of inflammation. On the other hand, when
inflammation occurs in a wild-type genetic background, inflammation fails to evoke
biglycan or decorin expression. Thus, it is likely that the underlying etiology for the
decreased latency to preterm birth in the Bgn+/−;Dcn−/− and Bgn−/−;Dcn+/− mice is a result
of a two hit hypothesis, in which a genetic predisposition is aggravated by an environmental
factor. Specifically, genetic susceptibility is compensated for, but the compensation is then
tempered by an environmental hit that deranges the compensation. This observation mirrors
clinical observations in patients with Ehlers-Danlos syndrome, who display a significantly
elevated incidence of preterm birth from PPROM compared to their unaffected siblings
(Barabas 1966; Yen et al. 2006). The progeroid variant of Ehlers-Danlos syndrome displays
a mutation leading to the secretion of abnormal, non-glycosylated biglycan and decorin
(Quentin et al. 1990). Further support is lent to the concept of PPROM via connective tissue
genetic abnormalities exacerbated by inflammation by the fact that women with a history of
multiple PPROM have undiagnosed connective tissue anomalies similar to Ehlers-Danlos
syndrome (Hermanns-Le et al. 2005).
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One caveat to these observations is that the mice used for the in vivo E. coli injection
experiments are heterozygous/homozygous and homozygous/heterozygous biglycan/decorin
nulls (Bgn+/−;Dcn−/− and Bgn−/−;Dcn+/−). However, based on our prior data (Calmus et al.
2011), it is likely that our observations are a similar but tempered response compared to the
homozygous/homozygous double nulls (Bgn−/−;Dcn−/−), which have too severe a
phenotype to lend themselves to these types of experiments. At the same time, these
observations are likely an exaggerated response compared to the single nulls (Bgn−/− or
Dcn−/−), on which we have performed the in vitro component of this study.
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When both biglycan and decorin are present in fetal membranes, inflammation leads to a
decrease in MMP-8 protein expression, perhaps as a protective mechanism to counteract the
membrane destructive/remodeling effects. Alternately, MMP-8 could be transcribed at the
typical rate but secondary to inflammation there is higher turnover as it is being used to
degrade the fetal membranes. In the absence of biglycan, MMP-8 protein expression is
decreased in a manner similar to the wild-type. In the decorin null, on the other hand,
MMP-8 protein expression is unchanged. Thus, the expected MMP-8 decrease in the
presence of inflammation does not occur in the absence of decorin, but does occur in the
absence of biglycan, indicating a role for decorin in the MMP-8 signaling pathway under
inflammatory circumstances. Similarly, exogenous decorin gain-of-function experiments
confirm that decorin regulates components of this pathway (Wu et al. 2014). These findings
are similar to our previous findings, in which MMP-8 and MMP-9 gene and protein
expression, as well as MMP-13 gene transcription increases in fetal membranes close to
term (embryonic day 18) in the absence of decorin, but not in the absence of biglycan (Wu
et al. 2014), suggesting that decorin is a membrane stabilizing factor. Furthermore, decorin
suppresses the expression and activity of two MMPs associated with PPROM, MMP-2 and
MMP-9 (Neill et al. 2012a). Also, decorin decreases prior to parturition as ozen in liquid
nitrogen and stored at hile biglycan increases (Meinert et al. 2007). Interestingly, however,
decorin induces the synthesis of a number of MMPs, including MMP-1, -2 and -14
(Schonherr et al. 2001) and during early gestation (embryonic day 12), the absence of
decorin leads to a decrease in MMP-8 and -9 protein expression in fetal membranes. This
suggests a role for decorin in extracellular matrix remodeling in early gestation as opposed
to its membrane stabilizing role in late gestation and in inflammation.
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Our data indicate that biglycan and decorin are both necessary for the maintenance of
appropriate collagen α1VI levels in the setting of inflammation. Gene transcription of
collagen α1VI is unchanged with inflammation or in the absence of biglycan or decorin.
Protein expression, however, increases in the absence of biglycan or decorin in the setting of
inflammation. One possible explanation for the increase in collagen α1VI in the absence of
both biglycan and decorin is compensation for the structural role of the absent
proteoglycans. In the setting of two hits, a genetic defect as well as inflammation, the
increase in collagen α1VI expression may be a protective strategy to stabilize the fetal
membranes. Decreased decorin in the kidney leads to increased accumulation of
extracellular matrix with increased biglycan expression (Merline et al. 2009) and the
absence of decorin leads to hepatic fibrosis (Baghy et al. 2011). Thus, alternately, the
increase in collagen α1VI in the absence of these SLRPs may be a reflection of the antifibrotic role of these proteoglycans.
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The diverse MMP-8 and collagen α1VI expression profiles in the absence of biglycan or
decorin suggest that the two SLRPs signal via discrete pathways. Given that they
compensate for each other, if they exerted their signaling via one common pathway, one
would expect the MMP-8 and collagen α1VI levels to be unchanged between the wild-type
and either null mouse. It is likely that compensation is not complete, coupled with some
level of discrete functions. Biglycan and decorin play differential roles in mouse fetal
membrane TGFβ signaling, leading to differential expression of the MMPs -8, -9 and -13,
TIMPs -1, -2, -3 and -4, and collagen α1VI (Wu et al. 2014). Furthermore, the differences in
Mol Reprod Dev. Author manuscript; available in PMC 2016 May 01.
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expression and function may be related to the mid-pregnancy gestational age studied here,
since biglycan and decorin play distinct signaling roles in a gestational age dependent
manner (Wu et al. 2014).
Biglycan plays a role in inflammatory signaling as an inflammatory cascade activator via its
role as a ligand for Toll-like receptors 2 and 4 (Babelova et al. 2009; Moreth et al. 2014;
Zeng-Brouwers et al. 2014). Furthermore, decorin expression is evoked by septic
inflammation, and decorin boosts inflammatory response in both sepsis and cancer (Merline
et al. 2011). Thus, the role of biglycan and decorin in the maintenance of fetal membrane
integrity in the setting of inflammation is likely to reflect complex interactions between their
roles as connective tissue stabilizing proteins and their roles as extracellular matrix
proinflammatory signaling molecules.
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In summary, our findings suggest that biglycan and decorin compensate for each other in the
fetal membranes but lose their ability to do so in the setting of inflammation, leading to
decreased latency to preterm birth, and thus preterm birth earlier than inflammation alone
would have led to. Furthermore, our findings suggest that biglycan and decorin play discrete
roles in fetal membrane signaling pathways leading to changes in expression of MMP-8 and
collagen α1VI, two components of the fetal membrane extracellular matrix that play a role
in the pathophysiology of PPROM.

4. Materials and Methods
4.1. Mouse husbandry and genotyping

Author Manuscript
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Wild-type mice (C3H) were purchased from Jackson Laboratories (Bar Harbor, ME). A
Bgn−/− breeding pair (C3H) (generated by Marian Young (Xu et al. 1998)) was a gift from
Justin Fallon. A Dcn+/− breeding pair (C57BL/6) was mated to the birth of homozygous null
pups, which were then bred to establish the Dcn−/− colony. A Bgn−/− female was crossed
with a Dcn−/− male to establish double heterozygous breeding pairs (Bgn+/−;Dcn+/− and
Bgn−/0;Dcn+/−). These pairs were mated to breed Bgn+/−;Dcn−/− and Bgn−/−;Dcn+/−
heterozygous-homozygous null pups. Breeding pairs were set up for mating at 5–7 weeks of
age. Plugs were checked each morning, and the day of the plug was defined as embryonic
day 0. Dams that were sacrificed at embryonic day 15 for tissue harvesting were sacrificed
between 4 and 5 hours after E. coli or PBS injection. Approval was obtained from the
Lifespan Institutional Animal Care and Use Committee. For genotyping, genomic DNA was
extracted from each 3 mm tail biopsy sample using the High Pure PCR Template
Preparation Kit (Roche, Mannheim, Germany). Polymerase chain reaction (PCR) was
performed using the Taq DNA Polymerase kit (New England Biolabs, Ipswich, MA) and the
PTC-200 thermal cycler. The PCR product was run on a 1.8% w/v agarose gel to visualize
the following diagnostic bands. The decorin PCR produced bands of 161 bp for the wildtype allele and 238 bp for the null allele. The biglycan PCR produced bands of 212 bp for
the wild-type allele and 310 bp for the null allele.
4.2. Bacteria preparation
Previously frozen E. coli was inoculated on an agar plate overnight. The next morning one
colony from the plate was incubated overnight in 10mL in Luria-Bertani (LB) broth (MP
Mol Reprod Dev. Author manuscript; available in PMC 2016 May 01.
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Biomedicals, Santa Ana, CA). The next morning, the culture was diluted 1:50 in fresh LB
broth and incubated until an optical density of 0.5–0.8 was detected at 600nm, indicating the
bacteria was in log phase growth. A more accurate bacterial concentration was determined
post hoc by the plating of 106 serial dilutions in triplicate. Colony counts were performed on
these plates the next morning. Colony forming units ranged from 3×106 to 1.4×107 CFU/ml.
4.3. Injection preparation

Author Manuscript

300mcl of the previously mentioned log phase bacterial broth was concentrated by
centrifugation with the addition of 700mcl clean LB broth. The resulting pellet was washed
with 1ml of sterile, room temperature phosphate buffered saline (PBS) and was concentrated
again via centrifugation. The PBS was decanted and the pellet was re-suspended in 0.5ml of
sterile, room temperature PBS. The resulting suspensions were drawn into 1ml tuberculin
syringes and injected intraperitoneally into pregnant embryonic day 15 mice of the
following genotypes: Bgn−/−;Dcn+/−, Bgn+/−;Dcn−/− and wild-type (Bgn+/+;Dcn+/+).
Vehicle controls of 0.5ml sterile, room temperature PBS were also used. In order to assess
preterm delivery rates, the mice were observed twice daily while health status and preterm
deliveries were recorded. Health status was determined using an adaptation of the Mouse
Sepsis Index scale (Biswas et al. 2002). The scale ranges from 5 for a normal healthy
clinical status to 0 for death. Four is defined as slight illness with ruffled fur and lethargy, 3
is moderate illness with severe lethargy, ruffled fur and hunched back, 2 is severe illness
with all signs of 3 plus exudative accumulation around the eyes, and 1 is a moribund state.
Mice of both null genotypes injected with E. coli did not differ significantly from wild-type
E. coli injected mice in their illness index. Nulls of both genotypes injected with E. coli had
a mean score of 3.75 (SD 0.58) and wild-type mice injected with E. coli a mean score of
3.87 (SD 0.73) (P= 0.7).
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Mice that were designated for tissue harvest were sacrificed 4 to 5 hours after E. coli or PBS
injection on embryonic day 15.
4.4. Western blotting

Author Manuscript

Fetal membranes from each genotype and condition were dissected at embryonic day 15
between 4 and 5 hours after E. coli or PBS injection and frozen at −80°C Tissue samples
were cut into small pieces and placed in 1.0 ml T-PER tissue protein extraction buffer
(Pierce, Rockford, IL) with one tablet of proteinase inhibitor cocktail per 10 ml buffer
(Roche, Basel, Switzerland). Tissue samples were then homogenized for 3×10s in an ice
bath and kept on ice for 30 min. The homogenate was centrifuged at 10,000 × g at 4 °C for 8
min. The supernatant was collected and stored at −80°C until use. Total protein content was
determined using the BCA assay (Pierce, Rockford, IL). 30 μg of total protein was loaded on
duplicate 10% SDS-polyacrylamide gels and subsequently blotted to a polyvinylidene
difluoride membrane. Following blocking in 5% milk in PBS-T buffer (PBS with 0.2%
Tween 20) for 30 min, each blot was incubated overnight at 4°C with primary antibody. The
blot was then washed with PBS-T buffer briefly and incubated with secondary antibody for
40 min. The Super-Signal West Pico chemiluminescent substrate kit (Pierce, Rockford, IL)
was used prior to development of the blot membrane. The bands were compared with
protein markers of known molecular size run in parallel on the same SDS-polyacrylamide

Mol Reprod Dev. Author manuscript; available in PMC 2016 May 01.

de Miranda de Araujo et al.

Page 9

Author Manuscript

gel (Bio-Rad, Hercules, CA). The membrane was stripped using Restore Western Blot
stripping buffer (Thermo Scientific, Waltham, MA) for 10 min and blocked with 5% milk
PBS-T for 20 min, then re-probed with anti-GAPDH antibody at a 1:800 dilution (Santa
Cruz Biotech, Santa Cruz, CA) as an internal standard. Immunoblots were digitally scanned
and densitometrically analyzed using Gel-Pro Analyzer (Media Cybernetics, Bethesda,
MDRelative optical density (specific protein band to GAPDH) was normalized to the wildtype with PBS injection band. The experiment was repeated with three individual sets of
samples.
4.5. Antibodies

Author Manuscript

The following antibodies were used: rabbit polyclonal anti-COLα1VI (sc-20649, dilution
1:800) and mouse monoclonal anti-GAPDH (sc-137179, dilution 1:1000) (Santa Cruz
Biotech, Santa Cruz, CA). Secondary antibody labeling was performed with anti-mouse and
anti-rabbit IgG horseradish peroxidase conjugate (Cell Signaling, Danvers, MA).
4.6. ELISA

Author Manuscript

Wild-type, Bgn−/− and Dcn−/− dams injected with PBS vehicle as wells as dams of each
genotype injected with E. coli were dissected at embryonic day 15 between 4 and 5 hours
after E. coli or PBS injection. Fetal membranes were collected and flash frozen in liquid
nitrogen and isopentane and stored at −80°C. Four whole fetal membranes from each
condition were used. Each fetal membrane sample was homogenized in 1mL of protein
lysate buffer (2.5ml Triton X and one tablet of Roche Complete EDTA-free Protease
Inhibitor filled to 50ml volume), flash frozen in liquid nitrogen and stored at −80°C until
used. Commercially available ELISA kits (MMP-8 from Anaspec, Fremont, CA; MMP-9
from Abnova, Taipei City, Taiwan) were run in triplicate according to the manufacturer’s
instructions. Plates were read on a Bio-Rad Laboratories Microplate Reader at 450nm.
4.7. RNA, cDNA preparation and quantitative PCR (qPCR)

Author Manuscript

Fetal membranes from wild-type, Bgn−/− and Dcn−/− dams injected with PBS vehicle as
wells as dams of each genotype injected with E. coli were dissected at embryonic day 15
between 4 and 5 hours after E. coli or PBS injection in 0.1mol l−1 phosphate-buffered saline,
pH 7.4, snap-frozen in liquid nitrogen and stored at −80°C. RNA extraction, genomic DNA
removal and conversion to cDNA was performed as described previously (Wu et al. 2014).
qPCR reactions were performed on the 7500 Fast Real-Time PCR System thermocycler
(Applied Biosystems, Foster City, CA) using the SYBR-Green method (Invitrogen,
Carlsbad, CA). Primers were designed using Primer-Blast primer design software (National
Library of Medicine, Bethesda, MD). GAPDH was used as a normalizer. Melting point
analysis of the product was performed to ensure the absence of alternative products or
primer dimers. Data analysis was performed via the comparative Ct method with a
validation experiment. A standard sample of RNA pooled from samples of wild-type as well
as biglycan and decorin null fetal membranes was used in each qPCR experiment as a
calibrator whose relative transcript level was defined as 1. qPCR analysis was performed in
triplicate. n=3–4 dams per genotype and condition.
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4.8 Primer sequences
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qPCR—GAPDH forward: CTCACAATTTCCATCCCAGAC, reverse:
TTTTTGGGTGCAGCGAAC; collagen α1VI forward:
CTGGTGAAGGAGAACTATGCAG, reverse: GTCTAGCAGGATGGTGATGTC;
biglycan forward: ATTGCCCTACCCAGAACTTGAC, reverse:
GCAGAGTATGAACCCTTTCCTG; decorin forward: TTCCTACTCGGCTGTGAGTC,
reverse: AAGTTGAATGGCAGAACGC.

Author Manuscript

Genotyping—Biglycan wild-type allele forward TGATGAGGAGGCTTCAGGTT,
reverse GCAGTGTGGTGTCAGGTGAG; biglycan null allele forward
TGTGGCTACTCACCTTGCTG, reverse GCCAGAGGCCACTTGTGTAG; decorin allele
forward CCTTCTGGCACAAGTCTCTTGG, decorin wild-type allele reverse
TCGAAGATGACACTGGCATCGG; decorin null allele reverse
TGGATGTGGAATGTGTGCGAG.
All primers were purchased from Invitrogen (Carlsbad, CA).
4.9 Statistical analysis
Analysis of differences in levels of gene and protein expression between genotypes was
performed using the Student’s t-test or, in the case of non-normally distributed data, the
nonparametric Mann-Whitney Rank Sum test. ANOVA and χ2 analysis were performed for
the in vivo experiments. Where appropriate, Bonferroni correction was performed for
multiple comparisons using the Student’s t-test. Analysis was performed using SigmaPlot
11.0 (San Jose, CA).
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PPROM

preterm premature rupture of fetal membranes

SLRP

small leucine-rich proteoglycan

Bgn−/−

biglycan null

Dcn−/−

decorin null

TGFβ

transforming growth factor β

MMP

matrix metalloproteinase

TIMP

tissue inhibitor of matrix metalloproteases
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[A] Days to delivery are decreased in the Bgn+/−;Dcn−/− and Bgn−/−;Dcn+/− dams injected
with E. coli compared to both the same genotype injected with PBS and the wild-type
regardless of injection category (p=0.001 via ANOVA). Error bars = SD. [B] While the
percentage of live pup births is decreased in the wild-type injected with E. coli compared to
PBS injected wild-type dams, it is decreased to zero in the Bgn+/−;Dcn−/− and
Bgn−/−;Dcn+/− dams injected with E. coli (p=0.004 via χ2). Gestational age embryonic day
15. n=3–8 per condition. Bgn=biglycan; Dcn=decorin.
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Biglycan and decorin compensate for each other in fetal membranes in the absence of
inflammation, but not in the presence of inflammation. [A] Biglycan gene expression is
increased in the PBS injected decorin null fetal membranes compared to wild-type (p=0.02);
this compensatory increase does not occur in the setting of inflammation [B] Decorin gene
expression is increased in the PBS-injected biglycan null fetal membranes compared to
wild-type (p=0.006); this compensatory increase does not occur in the setting of
inflammation, but decreased decorin gene expression occurs in the E. coli injected biglycan
null fetal membranes compared to the PBS injected biglycan null fetal membranes
(p=0.009). n=4 per genotype and condition. Error bars = SD. BgnKO=biglycan null;
DcnKO=decorin null; WT=wild-type; PBS=phosphate buffered saline. Student’s t-test was
performed for each set of data.
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MMP-8 expression is decreased in fetal membranes of E. coli injected mice in the wild-type
as well as the biglycan null mouse but not in the decorin null mouse. n=4 per genotype and
condition (p=0.03 and 0.028). Error bars = SD. BgnKO=biglycan null; DcnKO=decorin null;
WT=wild-type. Student’s t-test was performed for each set of data.
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Figure 4.
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In the setting of inflammation, collagen α1VI protein expression is increased in the biglycan
null and decorin null fetal membranes but not in the wild-type, while gene expression is
unchanged. [A] Collagen α1VI gene expression is unchanged in the biglycan null and
decorin null with or without inflammation compared to the wild-type. [B] Representative
Western blots and [C] Summary data demonstrating increased collagen α1VI protein
expression in the biglycan null and decorin null fetal membranes but not in the wild-type in
the setting of inflammation (P=0.05 and 0.03). n=4 per genotype and condition. Error bars =
SD. BgnKO=biglycan null; DcnKO=decorin null; WT=wild-type. Student’s t-test was
performed for each set of data.
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